CXCR2 and breast carcinoma: Some studies have shown that CXCR2, as an IL‐8 receptor, may promote breast cancer migration, invasion, and metastasis by promoting the migration of breast mesenchymal stem cells74 or mediate bone metastasis of breast cancer.75